Loading the section…
The price of CryoPort, Inc. (CYRX) on October 9, 2026 is 17.35 USD, +2.66% on the day. Over 52 weeks the stock traded between 7.61 USD and 18.36 USD; the price now sits 91% of the way up that range. Over the past year the price changed by +72.47%. The P/E ratio is 10.9, which is below the sector median (25.0). Market capitalization is 870.93 million USD, rank 118 among 372 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): +84.57 %
CryoPort, Inc. trades on Nasdaq under the ticker CYRX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks CYRX has traded between 7.61 $ and 18.36 $. As of 9 October 2026 the price stood 90.60 % of the way from the 52-week low to the high.
Over one year CYRX shares rose 72.47 %; over six months they rose 79.42 %. Volatility over 90 days is 37.44 %. Dividends are not included: this is price change only, as of 9 October 2026.
CYRX trades at a price-to-earnings ratio of 10.9, below the sector median of 25.0. Price to sales is 4.8, above the sector median of 4.0. Price to book is 1.8, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 16.90 | 17.66 | 16.90 | 17.35 | 479,900 |
| 8 October 2026 | 17.20 | 17.42 | 16.65 | 16.90 | 1M |
| 7 October 2026 | 17.36 | 17.55 | 17.13 | 17.35 | 1M |
| 6 October 2026 | 18.36 | 18.36 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027, US
CryoPort, Inc. reported revenue of 183M $ and net income of 80M $ over the last four quarters. Net margin is 43.59 %. Revenue changed by +13.97 % year over year. Earnings per share are 1.43 $. Market capitalisation is 871M $.
CYRX has a return on equity of 16.11 %, above the sector median of −41.68 %. Return on assets is 10.44 %, above the sector median of −32.11 %. Operating margin is −20.19 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 17.45 |
| 17.80 |
| 1M |
| 5 October 2026 | 17.30 | 18.24 | 17.30 | 18.14 | 1M |
| 2 October 2026 | 17.57 | 18.06 | 17.36 | 17.43 | 709,900 |
| 1 October 2026 | 17.40 | 17.53 | 17.00 | 17.36 | 1M |
| 30 September 2026 | 17.38 | 17.59 | 17.25 | 17.40 | 571,600 |
| 29 September 2026 | 17.38 | 17.55 | 17.06 | 17.32 | 931,700 |
| 28 September 2026 | 17.29 | 17.56 | 17.11 | 17.38 | 732,400 |
| 25 September 2026 | 17.36 | 17.59 | 17.22 | 17.41 | 729,900 |
| 24 September 2026 | 17.33 | 17.98 | 17.25 | 17.40 | 694,800 |
| 23 September 2026 | 17.46 | 17.64 | 17.00 | 17.49 | 568,900 |
| 22 September 2026 | 17.79 | 17.85 | 17.40 | 17.57 | 588,000 |
| 21 September 2026 | 17.17 | 17.65 | 17.00 | 17.62 | 760,600 |
| 18 September 2026 | 16.67 | 17.05 | 16.51 | 17.02 | 856,800 |
| 17 September 2026 | 16.80 | 17.12 | 16.55 | 16.78 | 753,500 |
| 16 September 2026 | 16.29 | 16.90 | 16.29 | 16.51 | 590,600 |
| 15 September 2026 | 15.83 | 16.43 | 15.83 | 16.31 | 688,300 |
| 14 September 2026 | 15.39 | 15.98 | 15.39 | 15.96 | 473,600 |